FLUAD
STN: 125510
Proper Name: Influenza Vaccine, Adjuvanted
Tradename: FLUAD
Manufacturer: Seqirus, Inc.
Indications:
- For active immunization of persons 65 years of age and older against influenza disease caused by influenza virus subtypes A and types B contained in the vaccine.
Product Information
Supporting Documents
- July 1, 2025 Approval Letter - FLUAD
- July 1, 2024 Approval Letter - FLUAD
- July 2, 2021 Approval Letter - FLUAD
- Statistical Review - FLUAD and FLUAD Quadrivalent
- Clinical Review - FLUAD and FLUAD Quadrivalent
- October 28, 2020 Approval Letter - Fluad and Fluad Quadrivalent
- July 2, 2020 Approval Letter Fluad and Fluad Quadrivalent
- May 13, 2020 Approval Letter - FLUAD
- July 2, 2019 Approval Letter - Fluad
- April 18, 2019 Approval Letter - FLUAD
- July 13, 2018 Approval Letter - Fluad
- July 7, 2017 Approval Letter - Fluad
- Approval History, Letters, Reviews, and Related Documents - FLUAD
- Supporting Documents older than three years - FLUAD